ORIX Growth Capital Invests in DrChrono
ORIX Growth Capital announced today that it has completed a growth capital debt investment in DrChrono, a leading electronic health record company with the first native app for iPhone and iPad.
“We are excited about DrChrono’s vision for healthcare, where recordkeeping tasks will be easy for both physicians and patients with the aid of a modern platform,” said David Orlandella, Managing Director at ORIX Growth Capital. “Having a cloud-based platform is part of the future, and DrChrono has developed an ecosystem of extendible apps that can be layered onto the platform, making it a powerful operating system of any medical practice.”
“The ORIX Growth Capital team has funded some of the best healthcare entrepreneurs and companies in the world,” said Daniel Kivatinos, Chief Operating Officer at DrChrono. “We are extremely excited about this partnership. With our platform and services evolving and maturing, we are in an excellent position to bring the DrChrono platform to larger facilities and specialty practices.”
All trademarks and logos noted are property of their respective owners and no endorsement or association of or with ORIX USA or its affiliates is intended or implied.
Select highlightsView all highlights
Dallas Innovates: Fort Worth Conversational AI Platform SmartAction Secures Funding, Brings Total Investment to $38M